Event : Making Sense of FDA’s (proposed) Rules for the Development and Approval of Biosimilars http://www.rsc.org/events/detail/7591/Making%20Sense%20of%20FDA%E2%80%99s%20(proposed)%20Rules%20for%20the%20Development%20and%20Approval%20of%20Biosimilars This is a feed for event : Making Sense of FDA’s (proposed) Rules for the Development and Approval of Biosimilars Thu, 11 Sep 2014 13:13:13 +0100 7591 7591 http://www.rsc.org/events/detail/7591/Making%20Sense%20of%20FDA%E2%80%99s%20(proposed)%20Rules%20for%20the%20Development%20and%20Approval%20of%20Biosimilars Making Sense of FDA’s (proposed) Rules for the Development and Approval of Biosimilars Event dates: 30 May 2012<br/>Event summary: This webinar will help you understand the process, requirements, quality and safety considerations for demonstrating biosimilarity to a Reference Product. You will learn about what type and how much<br/>Event Venue: Palo Alto, 94303, United States Thu, 11 Sep 2014 13:13:13 +0100 2014-09-11T13:13:13+01:00